GRI BIOPAR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4007 USD | -1.18% |
|
+2.72% | -94.02% |
| 04-16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
| 2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
- Stock Market
- Equities
- GRI Stock
- News GRI BIOPAR
- Transcripts